The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

NA
Aquaculture
Cardiomyopathy syndrome: A multi-task approach to reduce losses and improve knowledge
National Programme
National
Olav Breck
olav.breck@marineharvest.com
NA
NOFIMA - Norwegian Institute of Food, Fisheries and Aquaculture Research (Norway)NVI - Norwegian Veterinary Institute (Norway)
2008
2011
€ 2,105,677
https://www.fhf.no/prosjekter/prosjektbasen/900261/
Cardiomyopathy syndrome (CMS) is a severe cardiac disease in farmed Atlantic salmon. The disease has been diagnosed in Norway since mid 80s. CMS causes significant losses for the industry in the form of mortality at seawater sites and in connection with transport to the slaughter houses. As CMS generally affects large fish, the economic losses may be substantial, even though the cumulative mortality may not be very high. However, the biomass losses are substantial since the fish are mostly above 3 kg. In the first half of 2007, the accumulated CMS related biomass losses for Marine Harvest Norway (MHN) were 1200 tonnes. Based on MHN, representing ~25% of Norwegian salmon production and assuming that MHN losses reflect an average of whole industry, overall losses for Norwegian salmon industry can be estimated to >200 mill NOK/year. The CMS diagnosis is presently based on observations of clinical signs, autopsy and histopathology due to the lack of knowledge on aetiology, and the need to distinguish bet ween CMS and differential diagnoses such as heart and skeletal muscle inflammation (HSMI) and pancreas disease (PD). To comply with the CMS disease a multi-task project is suggested. The industry needs to find efficient methods for control and prevention of future outbreaks of CMS. This will be pursued by identification of risk factors associated with CMS by conducting epidemiological studies together with specific experiments that are aimed at nutritional and environmental risk factors. The mechanisms underlying the pathogenesis will be described, and improved diagnostic tools will be developed to improve differentiation of related cardiac pathologies and allow for early diagnosis. Based on this work the project will aim to identify causal factors lead ing to the development of CMS, improve diagnostic tools and suggest strategies for prevention and control to reduce the occurrence and consequences of the disease. Objectives: • To identify causal factors leading to the development of CMS • To improve diagnostic tools and suggest strategies for prevention • To control to reduce the occurrence and consequences of the disease Sub-goals 1. To identify risk factors associated with CMS outbreaks by conducting an epidemiological survey. 2. To evaluate potential risk factors based on current hypotheses on environmental and nutritional impact. 3. To describe disease mechanisms with particular focus on developing a better and broader understanding of pathogenesis. 4. To develop improved diagnostic tools, to improve differentiation of related cardiac pathologies and allow for early diagnosis.
Salmon; Diagnostic application; Disease; Fish; Fish health;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */